Quality Improvement in Citrus and Subtropical Products Res Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
 

Research Project: RECOVERY OF VALUE-ADDED PRODUCTS PERTAINING TO HEALTH AND FOOD USES FROM CITRUS PROCESSING WASTE

Location: Quality Improvement in Citrus and Subtropical Products Res

Title: Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on pg-p-mediated transport of talinolol in caco-2 cells

Authors
item Mertens-Talcott, Susanne - UNIV OF FLORIDA
item DE Castro, Whocely - UNIV OF FLORIDA
item Manthey, John
item Derendorf, Hartmut - UNIV OF FLORIDA
item Butterweck, Veronika - UNIV OF FLORIDA

Submitted to: Journal of Agricultural and Food Chemistry
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: January 30, 2007
Publication Date: March 10, 2007
Citation: Mertens-Talcott, S.U., De Castro, W.V., Manthey, J.A., Derendorf, H., Butterweck, V. 2007. Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on p-glycoprotein-mediated transport of talinolol in caco-2 cells. Journal of Agricultural and Food Chemistry. 55:2563-2568.

Interpretive Summary: There are proteins in the intestine that are involved in pumping out foreign compounds. One of these main "transport" protein is call P-gp. The transport activity of this proteins can be blocked by lipids, and so the transport by P-gp was measured in the presence of a number of very lipid-like compounds in citrus termed the polymethoxylated flavones. Results of this study show that these polymethoxylated flavones are powerful inhibitors of P-gp, and thus may influence the transport by P-gp, and thus may affect the bioavailability of certain foreign compounds, i.e. medications, etc., in humans.

Technical Abstract: Many studies investigating drug interactions with citrus compounds focus on the major grapefruit furanocoumarins bergamottin, dihydroxybergamottin and the flavonoid naringenin. This study evaluated the influence of polymethoxylated flavones (PMFs), tangeretin, nobiletin, 3,5,6,7,8,3,4'-heptamethoxyflavone, and sinensetin, as well as other minor-occuring citrus phenols hesperetin, limettin, 7-OH-coumarin, 7-geranyloxycoumarin, and eriodictyol on P-glycoprotein-mediated transport of the beta-blocker talinolol using Caco-2 cell monolayer model and to determine structure-function aspects of the interaction. The transport of talinolol across Caco-2 cells monolayers was determined in the absence and presence of distinct concentrations of the calcium-channel blocker verapamil (a known inhibitor of P-glycoprotein), and citrus compounds. A sigmoid dose-response model was used to fit the data and to estimate the IC50 values of the potential inhibitors. Results from this study show that PMFs significantly decreased talinolol transport from the basolateral to apical side, where tangeretin had the lowest IC50 of 3.2µmol/L, followed by nobiletin, heptamethoxyflavone, and sinensetin with IC50 of 3.5, 3.8 and 3.9 µmol/L, respectively. However, the efficacy of the compounds did not appear to be dependent on the number of methoxy-groups. Other citrus compounds did not have any significant effect on the transport of talinolol. This study suggests that PMFs have a high potential in the interaction with P-gp-mediated talinolol transport in Caco-2 cells. Based on their relatively low concentrations (</= 3 µg/ml) in citrus the clinical relevance of these interactions needs to be further elucidated in in vivo studies.

   

 
Project Team
Manthey, John
Luzio, Gary
Widmer, Wilbur - Bill
Cameron, Randall - Randy
 
Publications
   Publications
 
Related National Programs
  Quality and Utilization of Agricultural Products (306)
 
 
Last Modified: 05/22/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House